Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Colorcon
Boehringer Ingelheim
Medtronic

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

FLUDEOXYGLUCOSE F18 Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Fludeoxyglucose F18, and what generic alternatives are available?

Fludeoxyglucose F18 is a drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Cpdc, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Houston Cyclotron, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Lantheus Medical, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Petnet, Precision Nuclear, Queen Hamamatsu Pet, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Tx Md Anderson, Univ Utah Cyclotron, Weill Medcl Coll, Wi Medcl Cyclotron, and Wusm Cyclotron. and is included in forty-one NDAs.

The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.

Summary for FLUDEOXYGLUCOSE F18
Drug patent expirations by year for FLUDEOXYGLUCOSE F18
Recent Clinical Trials for FLUDEOXYGLUCOSE F18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CHU de Quebec-Universite LavalPhase 2
ECOG-ACRIN Cancer Research GroupPhase 3
Canary FoundationPhase 2

See all FLUDEOXYGLUCOSE F18 clinical trials

Pharmacology for FLUDEOXYGLUCOSE F18
Synonyms for FLUDEOXYGLUCOSE F18
(18)FDG
(2S,3R,4S,5S,6R)-3-fluoranyl-6-(hydroxymethyl)oxane-2,4,5-triol
[18F]FDG
[F-18]-FDG
105851-17-0
18DG
18FDG
2-(fluoro-(18)F)-2-deoxy-alpha-glucopyranose
2-(Fluoro-18F)-2-deoxy-alpha-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucose
2-deoxy-2-(fluoro-(18)F)-alpha-D-glucopyranose
2-Deoxy-2-(fluoro-18f)-a-D-glucopyranose
2-Deoxy-2-fluoro-(sup 18)F-alpha-D-glucopyranose
851D170
AC1L9OYT
AKOS006272016
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-(sup 18)F)-
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-18F)-
CHEBI:31617
CHEMBL1092067
D01843
F-18 FDG
Flucis
Fludeoxyglucose ((sup 18)F)
Fludeoxyglucose (18F)
Fludeoxyglucose (18F) (JAN/INN)
Fludeoxyglucose F 18
Fludeoxyglucose F 18 (TN)
Fludeoxyglucose F 18 (USP)
Fludeoxyglucose f 18 [USAN:USP]
FLUDEOXYGLUCOSE F-18
FLUORINE F 18 FLUORODEOXYGLUCOSE
Fluorodeoxyglucose F 18
MOLI000964
SBT3GBX27W
SCHEMBL135994
UNII-SBT3GBX27W
ZCXUVYAZINUVJD-AHXZWLDOSA-N

US Patents and Regulatory Information for FLUDEOXYGLUCOSE F18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Utah Cyclotron FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204498-001 Jun 23, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Sofie FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203591-001 Aug 31, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Petnet FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 079086-001 Feb 25, 2011 AP RX No Yes   Start Trial   Start Trial   Start Trial
Spectron Mrc Llc FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203911-001 Apr 22, 2015 RX No No   Start Trial   Start Trial   Start Trial
Precision Nuclear FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204546-001 Apr 7, 2015 RX No No   Start Trial   Start Trial   Start Trial
Downstate Clincl FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INJECTION 020306-001 Aug 19, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
Kreitchman Pet Ctr FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203942-001 Apr 11, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
AstraZeneca
Express Scripts
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.